ARCHIVES

FDA News: ODAC Clears Photofrin For Microinvasive NSCLC

This article is from The Cancer Letter archive.

Vol. 23 No. 37 | September 26, 1997

Download PDF Visit The Full Archive

Related Articles

House Passes Bill Giving FDA Authority Over Tobacco Products

April 10, 2009

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

November 29, 2013

Brigham & Women’s Suspends Controversial Morcellation Study As Apparent “Difference of Opinion” with FDA Comes to Light

December 5, 2014

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

February 25, 2011

Natural Substance Blocks Androgen Activity In Vitro

April 27, 2001

In Brief: Rogers Indicates He May Let Training Grant Bill Die

March 29, 1974